1. Home
  2. OCGN vs SWMR Comparison

OCGN vs SWMR Comparison

Compare OCGN & SWMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.29

Market Cap

419.8M

Sector

Health Care

ML Signal

HOLD

SWMR

Swarmer Inc Common Stock

N/A

Current Price

$39.69

Market Cap

453.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
OCGN
SWMR
Founded
2013
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
419.8M
453.1M
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
OCGN
SWMR
Price
$1.29
$39.69
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$9.75
N/A
AVG Volume (30 Days)
5.7M
345.2K
Earning Date
05-05-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
31.58
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$2,862.05
Revenue Next Year
$1,718.38
$177.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.93
$25.75
52 Week High
$2.73
$83.30

Technical Indicators

Market Signals
Indicator
OCGN
SWMR
Relative Strength Index (RSI) 40.03 46.76
Support Level $1.13 $38.60
Resistance Level $1.58 $52.10
Average True Range (ATR) 0.07 4.00
MACD -0.02 0.12
Stochastic Oscillator 18.75 44.07

Price Performance

Historical Comparison
OCGN
SWMR

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About SWMR Swarmer Inc Common Stock

Swarmer Inc is a provider of autonomous drone swarm software and AI solutions, specializing in vendor-agnostic technologies. It develops software platforms and artificial intelligence systems for defence applications, enabling military organisations to deploy and coordinate large-scale unmanned and autonomous systems. Its offerings include swarm coordination software, multi-domain unmanned systems integration, collaborative autonomy solutions, and command-and-control software for distributed robotic operations. Its key software and AI systems include: i) STYX AI Command & Control System, ii) MINAS Autonomy and Collaboration AI and iii) TRIDENT Embedded Drone Operating System. The company generates revenue through software license sales.

Share on Social Networks: